An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.
Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators.
Saraf A, et al. Among authors: singh s.
Nat Med. 2024 Apr 18. doi: 10.1038/s41591-024-02955-2. Online ahead of print.
Nat Med. 2024.
PMID: 38637636